81193 Ntrk3 translocation analysis
Also known as: NTRK3 translocation testing, NTRK3 fusion detection
Molecular analysis to detect NTRK3 gene rearrangements and translocations associated with secretory breast carcinoma and other malignancies.
In Plain Language
breast cancer gene test; cancer translocation detection
Clinical Context
Used to identify NTRK3 fusions in breast carcinomas and other cancers for therapeutic decision-making and treatment eligibility assessment.
RVU Information
CPT 81193 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Lab and pathology codes require an order from the treating provider with clinical indication. For molecular pathology and genetic testing, document the specific analytes tested and clinical rationale.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the Pathology & Lab category, 94% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code 81193?
CPT 81193 (Ntrk3 translocation analysis) is a Pathology & Lab code. Molecular analysis to detect NTRK3 gene rearrangements and translocations associated with secretory breast carcinoma and other malignancies.
Who uses CPT code 81193?
CPT 81193 is used by Oncology, Pathology, Molecular Medicine. Used to identify NTRK3 fusions in breast carcinomas and other cancers for therapeutic decision-making and treatment eligibility assessment.
When is CPT 81193 used?
Used to identify NTRK3 fusions in breast carcinomas and other cancers for therapeutic decision-making and treatment eligibility assessment.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.